Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer-Reference-Cited by-同舟云学术

Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer

Published:2010-09-22 Issue:12 Volume:101 Page:2601-2605
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Shimokata Tomoya,Ando Yuichi,Yasuda Yoshinari,Hamada Akinobu,Kawada Kenji,Saito Hideyuki,Matsuo Seiichi,Kondo Masashi,Imaizumi Kazuyoshi,Hasegawa Yoshinori

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01729.x/fullpdf

Reference23 articles.

1. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer;Jodrell;J Clin Oncol,1992

2. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in patients with normal and impaired renal function;Harland;Cancer Res,1984

3. Carboplatin dosage: prospective evaluation of a simple formula based on renal function;Calvert;J Clin Oncol,1989

4. Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics;Gandara;J Clin Oncol,2009

5. Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer;Belani;J Clin Oncol,1999

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Real-world Efficacy and Safety of Atezolizumab and Durvalumab in Combination With Chemotherapy for First-line Treatment of Extensive-stage Small-cell Lung Cancer;Anticancer Research;2024-06-26

2. Durvalumab plus carboplatin-etoposide treatment in a patient with small-cell lung cancer on hemodialysis: a case report and literature review;International Cancer Conference Journal;2023-12-21

3. Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022;Clinical and Experimental Nephrology;2023-10-25

4. Comparison of Real-World Efficacy and Safety of Atezolizumab and Durvalumab in Combination with Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer;2023-08-30

5. Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer;Cancer Medicine;2023-06-23